SRI, Amylyx Pharmaceuticals partner to identify ALS drug candidates
SRI and Amylyx have joined forces to develop new drug candidates to treat amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases.
Stay updated with breaking news from Menu Hover. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
SRI and Amylyx have joined forces to develop new drug candidates to treat amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases.
Mogrify has collaborated with Astellas Pharma to conduct research on in vivo regenerative medicine approaches to address sensorineural hearing loss.
Gerresheimer has significantly ramped up its glass and plastic production capacities in India. A new modern plant to produce high quality plastic containers and closures was built at
ViGeneron, a Germany-based gene therapy company, has entered a target-specific strategic collaboration and option agreement with Regeneron Pharmaceuticals.
Bristol Myers Squibb has obtained approval from the US FDA for Opdualag to treat unresectable or metastatic melanoma patients.